1887

Abstract

Kaposi's sarcoma-associated herpesvirus (KSHV) uses several strategies to counteract the interferon (IFN) system. In this study, the relationship of the protein LANA2 from KSHV to the IFN-activated protein kinase (PKR) and 2-5A system was analysed. It was found that LANA2 could not abrogate apoptosis or RNA degradation mediated by the 2-5A system. However, expression of LANA2 inhibited apoptosis triggered by PKR. LANA2 also counteracted the PKR-mediated inhibition of protein synthesis and partially blocked PKR-induced phosphorylation of eIF-2. Analysis of PKR-induced activation of caspases 3 and 9 revealed that LANA2 abrogated activation of caspase 3 but not of caspase 9. These findings show that LANA2 is able to interfere with downstream events triggered by PKR. Hence, LANA2 should be considered as a KSHV defence protein against IFN.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.19014-0
2003-06-01
2021-02-25
Loading full text...

Full text loading...

/deliver/fulltext/jgv/84/6/vir841463.html?itemId=/content/journal/jgv/10.1099/vir.0.19014-0&mimeType=html&fmt=ahah

References

  1. Baldwin A. S. Jr. 1996; The NF- κ B and I κ B proteins: new discoveries and insights. Annu Rev Immunol14:649–681
    [Google Scholar]
  2. Black T., Safer B., Hovanessian A., Katze M. G.. 1989; The cellular 68,000 M r protein kinase is highly autophosphorylated and activated yet significantly degraded during poliovirus infection: implications for translational regulation. J Virol63:2244–2251
    [Google Scholar]
  3. Burysek L., Pitha P. M.. 2001; Latently expressed human herpesvirus 8-encoded interferon regulatory factor 2 inhibits double-stranded RNA-activated protein kinase. J Virol75:2345–2352
    [Google Scholar]
  4. Burysek L., Yeow W. S., Lubyova B., Kellum M., Schafer S. L., Huang Y. Q., Pitha P. M.. 1999; Functional analysis of the HHV-8 encoded vIRF-1 and its association with cellular IRFs and p300. J Virol73:7334–7342
    [Google Scholar]
  5. Castelli J. A., Hassel B. A., Wood K. A., Li X.-L., Amemiya K., Dalakas M. C., Torrence P., Youle R. J.. 1997; A study of the interferon antiviral mechanism: apoptosis activation of the 2-5A system. J Exp Med186:967–972
    [Google Scholar]
  6. Chang Y., Cesarman E., Pessin M. S., Lee F., Culpepper J., Knowles D. M., Moore P. S.. 1994; Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science266:1865–1869
    [Google Scholar]
  7. Chong K. L., Feng L., Schappert K., Meurs E., Donahue T. F., Friesen J. D., Hovanessian A. G., Williams B. R.. 1992; Human p68 kinase exhibits growth suppression in yeast and homology to the translational regulator GCN2. EMBO J11:1553–1562
    [Google Scholar]
  8. Der S. D., Yang Y., Weissmann C., Williams B. R. G.. 1997; A double stranded RNA-activated protein kinase-dependent pathway mediating stress-induced apoptosis. Proc Natl Acad Sci U S A94:3279–3283
    [Google Scholar]
  9. Dever T. E., Sripriya R., McLachlin J. R., Lu J., Fabian J. R., Kimball S. R., Miller L. K.. 1998; Disruption of cellular translational control by a viral truncated eukaryotic translation initiation factor 2 α kinase homolog. Proc Natl Acad Sci U S A95:4164–4169
    [Google Scholar]
  10. Díaz-Guerra M., Rivas C., Esteban M.. 1997a; Inducible expression of the 2-5A-synthetase/RNaseL system results in inhibition of vaccinia virus replication. Virology227:220–228
    [Google Scholar]
  11. Díaz-Guerra M., Rivas C., Esteban M.. 1997b; Activation of the IFN-inducible enzyme RNaseL causes apoptosis of animal cells. Virology236:354–363
    [Google Scholar]
  12. Gale M. Jr, Katze M. G.. 1998; Molecular mechanisms of interferon resistance mediated by viral-directed inhibition of PKR, the interferon-induced protein kinase. Pharmacol Ther78:29–46
    [Google Scholar]
  13. Gale M. Jr, Korth M. J., Tang N. M., Tan S. L., Hopkins D. A., Dever T. E., Polyak S. J., Gretch D. R., Katze M. G.. 1997; Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein. Virology230:217–227
    [Google Scholar]
  14. Gale M. Jr, Blakely C. M., Kwieciszewski B.. 7 other authors 1998; Control of PKR protein kinase by hepatitis C virus nonstructural 5A protein: molecular mechanisms of kinase regulation. Mol Cell Biol18:5208–5218
    [Google Scholar]
  15. Gao S. J., Boshoff C., Jayachandra S., Weiss R. A., Chang Y., Moore P. S.. 1997; KSHV ORFK9 (vIRF) is an oncogene which inhibits the interferon signaling pathway. Oncogene15:1979–1985
    [Google Scholar]
  16. Gil J., Alcami J., Esteban M.. 1999; Induction of apoptosis by double-stranded-RNA dependent protein kinase (PKR) involves the α subunit of eukaryotic translation initiation factor 2 and NF- κ B. Mol Cell Biol19:4653–4663
    [Google Scholar]
  17. Gil J., Alcami J., Esteban M.. 2000; Activation of NF- κ B by the dsRNA dependent protein kinase, PKR involves the I κ B kinase complex. Oncogene19:1369–1378
    [Google Scholar]
  18. Gil J., Rullas J., Alcami J., Esteban M.. 2001; MC159L protein from the poxvirus molluscum contagiosum virus inhibits NF- κ B activation and apoptosis induced by PKR. J Gen Virol82:3027–3034
    [Google Scholar]
  19. Gil J., Garcia M. A., Esteban M.. 2002; Caspase 9 activation by the dsRNA-dependent protein kinase, PKR: molecular mechanism and relevance. FEBS Lett529:249–255
    [Google Scholar]
  20. Gonzalo R. M., Rodríguez J. R., Rodríguez D., Gonzalez-Aseguinolaza G., Larraga V., Esteban M.. 2001; Protective immune response against cutaneous leishmaniasis by prime-booster immunization regimens with vaccinia virus recombinants expressing Leishmania infantum p36/LACK and IL-12 in combination with purified p36. Microbes Infect3:701–711
    [Google Scholar]
  21. Goodbourn S., Didcock L., Randall R. E.. 2000; Interferons: cell signalling, immune modulation, antiviral response and virus countermeasures. J Gen Virol81:2341–2364
    [Google Scholar]
  22. Harada H., Taniguchi T., Taneka N.. 1998; The role of interferon regulatory factors in the interferon system and cell growth control. Biochimie88:641–650
    [Google Scholar]
  23. He B., Gross M., Roizman B.. 1997; The γ 134·5 protein of herpes simples virus 1 complexes with protein phosphatase 1 α to dephosphorylate the α subunit of the eukaryotic translation initiation factor 2 and preclude the shutoff of protein synthesis by double-stranded RNA-activated protein kinase. Proc Natl Acad Sci U S A94:843–848
    [Google Scholar]
  24. Hirt B.. 1967; Selective extraction of polyoma DNA from infected mouse cell cultures. J Mol Biol27:365–369
    [Google Scholar]
  25. Katze M. G., Decorato D., Safer B., Galabru J., Hovanessian A. G.. 1987; Adenovirus VAI RNA complexes with the 68,000 M r protein kinase to regulate its autophosphorylation and activity. EMBO J6:689–697
    [Google Scholar]
  26. Kumar A., Haque J., Lacoste J., Hiscott J., Williams B. R. G.. 1994; Double-stranded RNA-dependent protein kinase activates transcription factor NF- κ B by phosphorylating I κ B. Proc Natl Acad Sci U S A91:6288–6292
    [Google Scholar]
  27. Kunzi M. S., Pitha P. M.. 1998; The role of cytokines in viral infections. In Topley and Wilson's Microbiology and Microbial Infections , 9th edn.vol 1p– 193 Edited by Collier L., Balows A., Sussman M.. London: Arnold;
    [Google Scholar]
  28. Lee S. B., Esteban M.. 1993; The interferon-induced double-stranded RNA-activated human p68 protein kinase inhibits the replication of vaccinia virus. Virology193:1037–1041
    [Google Scholar]
  29. Lee S. B., Esteban M.. 1994; The interferon-induced double-stranded RNA-activated protein kinase induces apoptosis. Virology199:491–496
    [Google Scholar]
  30. Lee S. B., Bablaman R., Esteban M.. 1996; Regulated expression of the interferon-induced protein kinase p68 (PKR) by vaccinia virus recombinants inhibits the replication of vesicular stomatitis virus but not that of poliovirus. J Interferon Cytokine Res16:1073–1078
    [Google Scholar]
  31. Li M., Lee H., Guo J., Niepel F., Fleckenstein B., Ozato K., Jung J. U.. 1998; Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor. J Virol72:5433–5440
    [Google Scholar]
  32. Lloyd R. M., Shatkin A. J.. 1993; Translational stimulation by reovirus polypeptide sigma substitution for VAI RNA and inhibition of phosphorylation of the alpha subunit of eukaryotic initiation factor 2. J Virol66:6878–6884
    [Google Scholar]
  33. Lu Y., Wambach M., Katze M. G., Krug R. M.. 1995; Binding of the influenza virus NSI protein to double-stranded RNA inhibits the activation of the protein kinase that phosphorylates the eIF2 α translation initiation factor. Virology214:222–228
    [Google Scholar]
  34. Lubyova B., Pitha P. M.. 2000; Characterization of a novel human herpesvirus 8-encoded protein vIRF3, that shows homology to viral and cellular interferon regulatory factors. J Virol74:8194–8201
    [Google Scholar]
  35. Mamane Y., Heylbroeck C., Genin P.. 7 other authors 1999; Interferon regulatory factors: the next generation. Gene237:1–14
    [Google Scholar]
  36. Moore P. S., Gao S. J., Dominguez G.. 7 other authors 1996; Primary characterization of a herpesvirus agent associated with Kaposi's sarcoma. J Virol70:549–558
    [Google Scholar]
  37. Nguyen H., Hiscott J., Pitha P. M.. 1997; The growing family of interferon regulatory factors. Cytokine Growth Factor Rev8:293–312
    [Google Scholar]
  38. Petryshyn R., Chen J. J., London I. M.. 1984; Growth-related expression of a double-stranded RNA-dependent protein kinase in 3T3 cells. J Biol Chem259:14736–14742
    [Google Scholar]
  39. Ploegh H. L.. 1998; Viral strategies of immune evasions. Science280:248–253
    [Google Scholar]
  40. Rivas C., Thlick A. E., Parravicini C., Moore P. S., Chang Y.. 2001; Kaposi's sarcoma-associated herpesvirus LANA2 is a B-cell-specific latent viral protein that inhibits p53. J Virol75:429–438
    [Google Scholar]
  41. Rowlands A. G., Panniers R., Henshaw E. C.. 1988; The catalytic mechanism of guanine nucleotide exchange factor action and competitive inhibition by phosphorylated eukaryotic initiation factor 2. J Biol Chem263:5526–5533
    [Google Scholar]
  42. Samuel C. E.. 1991; Antiviral actions of interferon. Interferon-regulated cellular proteins and their surprisingly selective antiviral activities. Virology183:1–11
    [Google Scholar]
  43. Sarid R., Olsen S. J., Moore P. S.. 1999; Kaposi's sarcoma-associated herpesvirus: epidemiology, virology, and molecular biology. Adv Virus Res52:139–232
    [Google Scholar]
  44. Soulier J., Grollet L., Oksenhendler E.. 7 other authors 1995; Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood86:1275–1280
    [Google Scholar]
  45. Stark G. R., Kerr I. M., Williams B. R., Silverman R. H., Schreiber R. D.. 1998; How cells respond to interferons. Annu Rev Biochem67:227–264
    [Google Scholar]
  46. Taniguchi T., Ogasawara K., Takaoka A., Tanaka N.. 2001; IRF family of transcription factors as regulators of host defense. Annu Rev Immunol19:623–655
    [Google Scholar]
  47. Taylor D. R., Shi S. T., Romano P. R., Barber G. N., Lai M. M.. 1999; Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein. Science285:107–110
    [Google Scholar]
  48. Thornberry N. A., Lazebnik Y.. 1998; Caspases: enemies within. Science281:1312–1316
    [Google Scholar]
  49. Vazquez M. I., Esteban M.. 1999; Identification of the functional domains in the 14-kilodalton envelope protein (A27L) of vaccinia virus. J Virol73:9098–9109
    [Google Scholar]
  50. Vilcek J., Sen G.. 1996; Interferons and other cytokines. In Fields Virology , 3rd edn.vol 1 pp 375–399 Edited by Fields B. N., Knipe D. M., Howley P. M.. Philadelphia: Lippincott–Raven;
    [Google Scholar]
  51. Zhou A., Paranjape J., Brown T. L.. 8 other authors 1997; Interferon action and apoptosis are defective in mice devoid of 2′,5′-oligoadenylate-dependent RNase L. EMBO J16:6355–6363
    [Google Scholar]
  52. Zimring J. C., Goodbourn S., Offermann M. K.. 1998; Human herpesvirus 8 encodes an interferon regulatory factor (IRF) homolog that represses IRF-1 mediated transcription. J Virol72:701–707
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.19014-0
Loading
/content/journal/jgv/10.1099/vir.0.19014-0
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error